Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q42229340)
Watch
English
NF-κB in cancer: a matter of life and death
scientific article published on November 2011
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMCID
3392037
retrieved
19 October 2017
title
NF-κB in cancer: a matter of life and death
(English)
1 reference
stated in
Europe PubMed Central
PMCID
3392037
retrieved
19 October 2017
main subject
NF-κB
0 references
author name string
Bharat B Aggarwal
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMCID
3392037
retrieved
19 October 2017
Bokyung Sung
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMCID
3392037
retrieved
19 October 2017
publication date
1 November 2011
1 reference
stated in
Europe PubMed Central
PMCID
3392037
retrieved
19 October 2017
published in
Cancer Discovery
1 reference
stated in
Europe PubMed Central
PMCID
3392037
retrieved
19 October 2017
volume
1
1 reference
stated in
Europe PubMed Central
PMCID
3392037
retrieved
19 October 2017
issue
6
1 reference
stated in
Europe PubMed Central
PMCID
3392037
retrieved
19 October 2017
page(s)
469-471
1 reference
stated in
Europe PubMed Central
PMCID
3392037
retrieved
19 October 2017
cites work
Cell-selective inhibition of NF-κB signaling improves therapeutic index in a melanoma chemotherapy model
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392037
retrieved
26 October 2017
NF-κB addiction and its role in cancer: 'one size does not fit all'.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392037
retrieved
26 October 2017
Targeting inflammatory pathways by flavonoids for prevention and treatment of cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392037
retrieved
26 October 2017
Inhibiting NF-κB activation by small molecules as a therapeutic strategy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392037
retrieved
26 October 2017
NF-kappaB inhibition through proteasome inhibition or IKKbeta blockade increases the susceptibility of melanoma cells to cytostatic treatment through distinct pathways
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392037
retrieved
26 October 2017
Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392037
retrieved
26 October 2017
Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392037
retrieved
26 October 2017
KINK-1, a novel small-molecule inhibitor of IKKbeta, and the susceptibility of melanoma cells to antitumoral treatment
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392037
retrieved
26 October 2017
Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392037
retrieved
26 October 2017
Nuclear factor-kappaB: the enemy within
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392037
retrieved
26 October 2017
Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392037
retrieved
17 August 2018
The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392037
retrieved
17 August 2018
Nuclear Factor-kB Tumor Expression Predicts Response and Survival in Irinotecan-Refractory Metastatic Colorectal Cancer Treated With Cetuximab-Irinotecan Therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392037
retrieved
1 December 2018
Constitutive IkappaB kinase activity correlates with nuclear factor-kappaB activation in human melanoma cells
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22586649
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1158/2159-8290.CD-11-0260
1 reference
stated in
Europe PubMed Central
PMCID
3392037
retrieved
19 October 2017
PMCID
3392037
1 reference
stated in
Europe PubMed Central
PMCID
3392037
retrieved
19 October 2017
PubMed ID
22586649
1 reference
stated in
Europe PubMed Central
PMCID
3392037
retrieved
19 October 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
